Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Celularity (CELU) Invested Capital (2020 - 2025)

Celularity (CELU) has disclosed Invested Capital for 6 consecutive years, with -$38.0 million as the latest value for Q4 2025.

  • For Q4 2025, Invested Capital fell 184.82% year-over-year to -$38.0 million; the TTM value through Dec 2025 reached -$38.0 million, down 184.82%, while the annual FY2025 figure was -$38.0 million, 184.82% down from the prior year.
  • Invested Capital hit -$38.0 million in Q4 2025 for Celularity, down from -$15.8 million in the prior quarter.
  • Across five years, Invested Capital topped out at $236.5 million in Q4 2022 and bottomed at -$648.2 million in Q2 2021.
  • Average Invested Capital over 5 years is $2.9 million, with a median of $44.5 million recorded in 2023.
  • Year-over-year, Invested Capital skyrocketed 137.89% in 2022 and then crashed 191.49% in 2025.
  • Celularity's Invested Capital stood at $99.4 million in 2021, then skyrocketed by 137.89% to $236.5 million in 2022, then crashed by 75.4% to $58.2 million in 2023, then dropped by 23.06% to $44.8 million in 2024, then plummeted by 184.82% to -$38.0 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$38.0 million, -$15.8 million, and -$21.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.